Cargando…
Systematic review of catatonia treatment
OBJECTIVE: To investigate the evidence-based treatment of catatonia in adults. The secondary aim is to develop a treatment protocol. MATERIALS AND METHODS: A systematic review of published treatment articles (case series, cohort or randomized controlled studies) which examined the effects of particu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775747/ https://www.ncbi.nlm.nih.gov/pubmed/29398916 http://dx.doi.org/10.2147/NDT.S147897 |
_version_ | 1783293976722276352 |
---|---|
author | Pelzer, Anne CM van der Heijden, Frank MMA den Boer, Erik |
author_facet | Pelzer, Anne CM van der Heijden, Frank MMA den Boer, Erik |
author_sort | Pelzer, Anne CM |
collection | PubMed |
description | OBJECTIVE: To investigate the evidence-based treatment of catatonia in adults. The secondary aim is to develop a treatment protocol. MATERIALS AND METHODS: A systematic review of published treatment articles (case series, cohort or randomized controlled studies) which examined the effects of particular interventions for catatonia and/or catatonic symptoms in adult populations and used valid outcome measures was performed. The articles for this review were selected by searching the electronic databases of the Cochrane Library, MEDLINE, EMBASE and PSYCHINFO. RESULTS: Thirty-one articles met the inclusion criteria. Lorazepam and electroconvulsive therapy (ECT) proved to be the most investigated treatment interventions. The response percentages in Western studies varied between 66% and 100% for studies with lorazepam, while in Asian and Indian studies, they were 0% and 100%. For ECT, the response percentages are 59%–100%. There does not seem to be evidence for the use of antipsychotics in catatonic patients without any underlying psychotic disorder. CONCLUSION: Lorazepam and ECT are effective treatments for which clinical evidence is found in the literature. It is not possible to develop a treatment protocol because the evidence for catatonia management on the basis of the articles reviewed is limited. Stringent treatment studies on catatonia are warranted. |
format | Online Article Text |
id | pubmed-5775747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57757472018-02-02 Systematic review of catatonia treatment Pelzer, Anne CM van der Heijden, Frank MMA den Boer, Erik Neuropsychiatr Dis Treat Review OBJECTIVE: To investigate the evidence-based treatment of catatonia in adults. The secondary aim is to develop a treatment protocol. MATERIALS AND METHODS: A systematic review of published treatment articles (case series, cohort or randomized controlled studies) which examined the effects of particular interventions for catatonia and/or catatonic symptoms in adult populations and used valid outcome measures was performed. The articles for this review were selected by searching the electronic databases of the Cochrane Library, MEDLINE, EMBASE and PSYCHINFO. RESULTS: Thirty-one articles met the inclusion criteria. Lorazepam and electroconvulsive therapy (ECT) proved to be the most investigated treatment interventions. The response percentages in Western studies varied between 66% and 100% for studies with lorazepam, while in Asian and Indian studies, they were 0% and 100%. For ECT, the response percentages are 59%–100%. There does not seem to be evidence for the use of antipsychotics in catatonic patients without any underlying psychotic disorder. CONCLUSION: Lorazepam and ECT are effective treatments for which clinical evidence is found in the literature. It is not possible to develop a treatment protocol because the evidence for catatonia management on the basis of the articles reviewed is limited. Stringent treatment studies on catatonia are warranted. Dove Medical Press 2018-01-17 /pmc/articles/PMC5775747/ /pubmed/29398916 http://dx.doi.org/10.2147/NDT.S147897 Text en © 2018 Pelzer et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Pelzer, Anne CM van der Heijden, Frank MMA den Boer, Erik Systematic review of catatonia treatment |
title | Systematic review of catatonia treatment |
title_full | Systematic review of catatonia treatment |
title_fullStr | Systematic review of catatonia treatment |
title_full_unstemmed | Systematic review of catatonia treatment |
title_short | Systematic review of catatonia treatment |
title_sort | systematic review of catatonia treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775747/ https://www.ncbi.nlm.nih.gov/pubmed/29398916 http://dx.doi.org/10.2147/NDT.S147897 |
work_keys_str_mv | AT pelzerannecm systematicreviewofcatatoniatreatment AT vanderheijdenfrankmma systematicreviewofcatatoniatreatment AT denboererik systematicreviewofcatatoniatreatment |